These findings were supplemented by the analysis of the correlations between ANXA1 mRNA levels and markers of different immune cell types [129], revealing a significant association between ANXA1 expression and the detection of myeloid DCs and monocytes in the TME of several cancer types, including renal cancer, breast cancer, and CRC [129]. Here, ANXA1 is linked to breast cancer.